课题基金 / 基金详情

Molecular Regulation of Hepatic Transporters

Molecular Regulation of Hepatic Transporters
肝脏转运蛋白的分子调控
批准号:
7256906
负责人:
SAUL J. KARPEN
金额:
$29.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-01 至 2011-03-31
关键词:
ABCC1 geneAbbreviationsAcuteAcute-Phase ReactionAnionsAnti-Inflammatory AgentsAttenuatedBile AcidsBile fluidBindingCarrier ProteinsCationsCholestasisCholesterolCholic AcidCholic AcidsChronicCurcuminDataDeoxycholic AcidDexamethasoneDigestive System DisordersDirect RepeatsEffectivenessEnhancersFunctional disorderGene ExpressionGene ProteinsGenesGlucocorticoidsGlutathione S-TransferaseGoalsGreen Fluorescent ProteinsHepaticHepatobiliaryHepatocyteIn VitroIndividualInflammationInflammatoryInterleukin-1InterventionKnock-outLigandsLinkLipopolysaccharidesLithocholic AcidLiverLiver diseasesLocationMAPK8 geneMAPK9 geneMG132MapsMediatingMediator of activation proteinMembraneMembrane ProteinsMitogen-Activated Protein KinasesModelingModificationMolecularMolecular TargetMulti-Drug ResistanceMusNuclearNuclear ExportNuclear ReceptorsP-GlycoproteinsPathway interactionsPhospholipidsPhosphorylationPhosphotransferasesPhysiologicalPhysiologyPost-Translational Protein ProcessingPost-Translational RegulationProteasome InhibitionProteasome InhibitorProteinsPumpRXRReactionRegulationResearch PersonnelRetinoic Acid ReceptorReverse Transcriptase Polymerase Chain ReactionRoleSignal PathwaySignal TransductionSiteTestingTherapeutic InterventionTimeTranscription CoactivatorTranscription Factor AP-1Tumor Necrosis Factor-alphaTumor Necrosis FactorsUbiquitinUbiquitinationZalcitabinealitretinoinbasebile acid transporterbile saltschicken DcoHalpha proteincytokinedesignextracellularfunctional disabilityhepatocyte nuclear factorhuman TNF proteinin vitro Modelin vivoinhibitor/antagonistmacromolecular assemblymembermulticatalytic endopeptidase complexnon-genomicnovel therapeuticspolypeptidepregnane X receptorpromoterprotein activationprotein expressionreceptorresearch studyresponserosiglitazonestress-activated protein kinase 1transcription factor

项目摘要

项目成果

SAUL J. KARPEN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):肝脏对炎症反应的中心特征之一是抑制一系列核心生理功能,包括维持胆汁酸肝胆运输所必需的功能。除了转运蛋白膜表达和功能的翻译后调控外,基于炎症的细胞信号通路作用于核靶点,转录抑制必需胆汁酸转运体Ntcp和Bsep的表达。II型NR超家族中心成员和异源二聚体伴侣rxrα是这两个基因的主要转录激活因子,其核活性被炎症细胞信号迅速抑制。rxrα靶基因表达的减少导致肝细胞的多种功能损伤和损伤。细胞信号通路如何抑制RXRalpha功能尚不清楚,这是本应用中提出的探索和干预的基础。整体统一的假设是,炎症细胞信号通路通过翻译后修饰、核输出和蛋白酶体降解的协调级联降低rxrα的核活性。以下四个目标将确定炎症介导的胆汁淤积的潜在生理学和病理生理学,并探索新的治疗方法。目的1:明确介导il -1 β诱导rxrα核输出的分子机制。目的2:确定rxrα的泛素化和蛋白酶体降解在响应il -1诱导的信号通路中的作用。目的3:探索胆汁酸和il -1 - β介导的通路之间的串扰,从而改变rxrα的功能。目的4:探讨抗炎药对IPS肝炎症模型中转运体基因及蛋白表达的影响。通过体外和体内结合的方法,我们可以探索旨在恢复rxrα功能、肝胆转运蛋白功能和胆汁流动的机制、介质和潜在的治疗干预措施,在肝脏炎症介导的细胞信号传导环境中。这些研究的最终目标是为测试专门设计用于干扰炎症介导途径的破坏性后果的疗法提供合理的分子靶点,炎症介导途径几乎参与所有形式的急性和慢性肝脏疾病。
英文摘要
DESCRIPTION (provided by applicant): One of the central features of the hepatic response to inflammation is the suppression of a broad array of core physiological functions, including those essential to maintaining hepatobiliary transport of bile acids. In addition to post-translational regulation of transporter protein membrane expression and function, inflammation-based cell signaling pathways act on nuclear targets to transcriptionally suppress the expression of the essential bile acid transporters Ntcp and Bsep. The central Type II NR superfamily member and heterodimer partner RXRalpha is a major transcriptional activator of these two genes, and its nuclear activity is rapidly suppressed by inflammation-based cell signaling. Reduced RXRalpha target gene expression leads to multiple functional impairments and damage to hepatocytes. How cell signaling pathways suppress RXRalpha function is unknown, and forms the basis for the explorations and interventions proposed in this application. The overall unifying hypothesis is that inflammatory cell signaling pathways reduce nuclear activity of RXRalpha via a coordinated cascade of post-translational modification, nuclear export and proteasomal degradation. The following four aims will determine the underlying physiology and pathophysiology of inflammation-mediated cholestasis and explore novel therapeutics. Aim 1: Define the molecular mechanisms mediating IL-1beta-induced nuclear export of RXRalpha. Aim 2: Determine roles for ubiquitination and proteasomal degradation of RXRalpha in response to IL-1beta- induced signaling pathways. Aim 3: Explore crosstalk between bile acid and IL-1beta-mediated pathways that modify RXRalpha function. Aim 4: Investigate the effects of anti-inflammatory agents on transporter gene and protein expression in the IPS model of hepatic inflammation. It is through a combined in vitro and in vivo approach that we can explore the mechanisms, mediators, and potential therapeutic interventions aimed at restoring RXRalpha function, hepatobiliary transporter function, and bile flow, in the setting of inflammation-mediated cell signaling in liver. The ultimate goal of these studies is to provide rational molecular targets for the testing of therapies specifically designed to interfere with the damaging consequences of inflammation-mediated pathways, which are engaged in nearly all forms of acute and chronic liver diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modeling genetic contributions to biliary atresia
  • 批准号:
    10639240
  • 项目类别:
  • 资助金额:
    $64.01万
  • 财政年份:
    2023
  • 负责人:
    SAUL J. KARPEN
  • 依托单位:
Research Training in Translational Gastroenterology and Hepatology
  • 批准号:
    10410926
  • 项目类别:
  • 资助金额:
    $7.65万
  • 财政年份:
    2016
  • 负责人:
    SAUL J. KARPEN
  • 依托单位:
Research Training in Translational Gastroenterology and Hepatology
  • 批准号:
    9073070
  • 项目类别:
  • 资助金额:
    $15.23万
  • 财政年份:
    2016
  • 负责人:
    SAUL J. KARPEN
  • 依托单位:
Research Training in Translational Gastroenterology and Hepatology
  • 批准号:
    9280922
  • 项目类别:
  • 资助金额:
    $29.23万
  • 财政年份:
    2016
  • 负责人:
    SAUL J. KARPEN
  • 依托单位:
海外基金